The largest database of trusted experimental protocols

215 protocols using celltrace violet ctv

1

In Vivo Migration Assay of BMDCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vivo migration assays were performed as previously described [19 (link)]. Briefly, LPS-stimulated BMDC from Actin GFP knock in mice (Inhα +/+) and BMDC from Inhα -/- mice stained with Cell Trace Violet (CTV) (Life Technologies), according to manufacturer’s instructions, were mixed 1:1 in sterile PBS. Viability of labeled cells previous to and after the in vivo transfer was 85–90%. A total of 2 x 106 cells in 50μl were injected in left footpad and, as a control, 50μl of PBS in right footpad of 6–9 week-old female C57BL/6 mice. After 48 hours, popliteal lymph nodes were extracted and stained with viability dye Aqua Zombie (Invitrogen) and anti-CD11c PE (Tonbo).
+ Open protocol
+ Expand
2

Tracking PBMC proliferation in co-culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were labeled with CellTrace Violet (CTV, 5 μM) (Life Technologies) to track proliferation and activated with 2.5 μg/mL phytohemagglutinin (PHA) (Sigma). hISCs or BM-MSCs were seeded in 96 well-plates at four densities (5 × 103, 104, 2 × 104, or 4 × 104 cells/well) in respective media during 24 h to allow cells to adhere. Then, activated PBMCs were added at the concentration of 2.105 cells/well on hISCs or BM-MSCs in co-culture medium consisting in IMDM, 25 mM HEPES, supplemented with 10% inactivated fetal bovine serum, 1 mM sodium pyruvate, 0.1 mM non-essential amino-acids, 0.25 mM beta-mercaptoethanol, 2 mM glutamine, 100 IU/mL penicillin, and 100 μg/mL streptomycin. As control condition, activated PBMCs were cultured alone. After 96 h of co-culture, PBMCs were harvested and proliferation was quantified by flow cytometry using a FACSCanto cytometer (BD Bioscience) on the basis of CTV dilution. Results are expressed as the percentage of proliferation of stimulated PBMCs and normalized to 100% for activated PBMCs alone.
+ Open protocol
+ Expand
3

In Vivo Cytotoxicity Assay for Influenza

Check if the same lab product or an alternative is used in the 5 most similar protocols

In vivo cellular cytotoxicity assay were adapted from Durward et al. (30 (link)). In brief, splenocytes were harvested and single cell suspensions prepared. Splenocytes were incubated with the MHC class I restricted influenza HA (Cal07) peptide IYSTVASSL, the NP peptide (RLIQNSLTIERMVLS), or a negative control peptide, at a density of 5x107 cells/mL for 1 h at 4°C followed by 30 min incubation at 37°C. Peptide‐loaded cells were washed twice in PBS and subsequently stained with 5 μM CellTrace Violet (CTV) (C34557, Life Technologies) (HA peptide loaded cells), or 1 μM CellTrace Far Red (CTFR) (C34564, Life Technologies) (NP peptide loaded), or double stain (CTV and CTFR) (negative control) at a density of 5x107 cells/mL for 20 min at 37°C. Cells were mixed in equal ratios (1:1:1), and a total of 15x106 cells injected i.v. in a 100µl volume to vaccinated mice. Spleens were harvested 16h later, single cell suspensions prepared, and the presence of peptide loaded cells investigated by flow cytometry. The ratio of CTV to CTV/CTFR or CTFR to CTV/CTFR cells were calculated as % specific lysis = [1 − (average ratio in group with NaCl vaccinated mice/experimental ratio)].
+ Open protocol
+ Expand
4

Adoptive Transfer of Tumor-Specific T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
2C CD8+ T cell receptor (TCR) transgenic (Tg) T cells specific for the SIY antigen in the context of Kb were purified from spleens of 2C/C57BL/6 mice by positive selection using a CD8 microbead kit according to the manufacturer’s protocol (Miltenyi). Purified 2C T cells were labeled with CellTrace Violet (CTV) (Life Technologies) according to the manufacturer’s protocol. 106 CTV-labeled 2C T cells were injected into C57BL/6 mice IV. One day later, mice received 106 C1498.SIY cells IV. DMXAA or vehicle was administered as indicated. Seven days later, spleens were harvested, stained with anti-CD8, anti-Thy1.2 and anti-1B2 antibodies (the 1B2 monclonal antibody recognizes the 2C TCR), followed by secondary labeling with streptavidin-PE. Flow cytometry analysis was then performed.
+ Open protocol
+ Expand
5

T cell proliferation with MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh splenocytes or purified CD4+ T cells were labeled with CellTrace Violet (CTV) (Life-Technology, Saint Aubin, France) prior to being cocultured with or without WT MSC or Gilz-/- MSC at a 1:10 MSC:T cell ratio in presence of 5 µg/mL of concanavalin (ConA) (Sigma-Aldrich). After 72 h, the proliferation of T cells was quantified by flow cytometry.
+ Open protocol
+ Expand
6

Isolation and Expansion of Memory-like NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal donor PBMCs were obtained from anonymous healthy platelet donors. NK cells were purified using RosetteSep (STEMCELL technologies; routinely >95% CD56+ CD3). Memory-like and control NK cells were generated as previously described (5 ). Cells were maintained in 1 ng/mL IL-15, with media changes every 2–3 days. For proliferation assays, cells were labeled with 2.5 μM CellTrace violet (CTV, Life Technologies) for 15 minutes at 37C.
+ Open protocol
+ Expand
7

Treg-Mediated Suppression of Colitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tregs from control and Esrrg-cKO splenocytes were isolated, either purified using Treg isolation kit II (Miltenyi Biotec) with the AutoMACS Pro (Miltenyi Biotec) or sorted as FOXP3-YFP+ with the S3e Cell Sorter (Bio-Rad). CD45.1+CD4+CD25 Teff cells from B6.SJL mice were labeled with CellTrace Violet (CTV) (Life Technologies, Thermo Fisher Scientific). Dendritic cells (DCs) were isolated from B6N mice by positive selection with anti-CD11c isolation kit (Miltenyi Biotec). CD45.2+CD4+CD25+ Tregs were incubated with Teff cells (6.6 × 104) at a 1:1 to 1:4 ratio in the presence of DCs (1 × 104) and soluble anti-CD3e antibody (1 μg/mL, BD Biosciences 145-2C11) for 3 days (74 (link)). The proliferation of CD45.1+ Teff cells was determined by the dilution of CTV, and the proliferation index was calculated with the FlowJo software.
For the experimental colitis model, B6.Rag–/– mice were injected i.v. with sorted CD4+FOXP3 Teff cells (0.4 × 106) either alone or with control or Esrrg-cKO Tregs (0.1 × 106). Mice were weighed and examined weekly and euthanized at week 13. Splenocytes were analyzed with flow cytometry, and colons were fixed and stained with H&E or anti-CD45 (1:25 dilution; BD Pharmingen 30F11). Infiltrating lymphocytes in colon were quantified with Imagescope.
+ Open protocol
+ Expand
8

Splenocyte Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the proliferative capacity of cells, splenocytes were stained with 1μM Cell Trace Violet (CTV, Life Technologies) in PBS at 37 C for 10 minutes. Stained cells were washed 3 times with complete media and then stimulated in the presence of OVA257-264. Cells were collected at indicated time points, stained with anti-CD8α (clone 53–6.7, BioLegend) and evaluated via flow cytometry.
+ Open protocol
+ Expand
9

Treg cell-mediated suppression of effector T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Current and exTreg cells were sorted based on expression of YFP and RFP. Naive effector cells (CD4+CD25CD44loCD62Lhi) cells were sorted from spleens and peripheral LNs of CD45.1 mice and were labeled with cell trace violet (CTV) (Life Technologies) according to manufacturer’s instruction. Cell sorting was done using FACSAria (BD Biosciences). Feeder cells were prepared from spleens of B6 mice and CD4 T cells were depleted using CD4+ magnetic beads (Miltenyi Biotec, Auburn, CA) and then were irradiated with 3000 rads. Feeders were cultured with naive effector T cells at a ratio of 3:1 in U-shaped 96 well plates. Sorted current or exTreg cells were added at a ratio of 1:1, 1:2, 1:4, 1:8 or not added for effectors only wells. All wells, except for unstimulated wells, were stimulated with soluble αCD3 antibody at 2.5 μg ml−1. All cells were cultured in RPMI media supplemented with 10% FCS, L-glutamine, penicillin and streptomycin, β-mercaptoethanol. Cells were harvested 4 days following stimulation and the percentage of effector CD45.1 cells that diluted CTV was determined.
+ Open protocol
+ Expand
10

Evaluating Treg-mediated Suppression of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naive CD45.2+CD8+ T responder cells (Tresp) were negatively sorted using the EasySep Mouse CD8+ T Cell Isolation kit (STEMCELL Technologies Inc.) and stained with CellTrace Violet (CTV; Life Technologies, Carlsbad, CA). CD45.1+CD4+FoxP3-EGFP T cells that had experienced HD Lm ΔactA-Ova infection for 24 h in C57BL/6 mice were re-isolated using the EasySep Mouse CD4+ T Cell Isolation kit (STEMCELL Technologies Inc.) followed by fluorescent cell sorting CD45.1+CD45.2FoxP3-EGFP+ and CD45.1+CD45.2FoxP3-EGFP cells. 2.5 × 104 CD45.2+CD8+ Tresp were placed in co-culture with graded numbers of sex-matched, magnetic/fluorescent cell sorted CD45.1+FoxP3-EGFP+ (Treg) or EGFP (conventional) CD4+ T cells and 1.25 mL washed Mouse T-Activator anti-CD3/CD28 Dynabeads (GIBCO) in a 96-well round-bottom plate for 72 h. Cell proliferation of CD45.2+CD8+ Tresp was determined by flow cytometry based on dilution of CTV. Percent suppression was calculated as the percent difference in absolute number of dividing Tresp in wells containing EGFP+ or EGFP CD4+ T cells to the average absolute number of dividing Tresp in wells without addition of EGFP+ or EGFP CD4+ T cells. Replication index, representative of only Tresp that had responded to anti-CD3/CD28 stimulation, was also determined for the cultures.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!